Boston Scientific received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA's 510(k) ...

Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...

This was the stock's third consecutive day of losses.

We recently published a list of Jim Cramer Put These 16 Stocks Under a Microscope. In this article, we are going to take a ...

Boston Scientific Corp. closed 4.20% short of its 52-week high of $107.17, which the company achieved on February 5th.

Bearish flow noted in Boston Scientific (BSX) with 3,259 puts trading, or 1.6x expected. Most active are 3/28 weekly 100 puts and 4/4 weekly 101 ...

Boston Scientific (BSX) closed the latest trading day at $102.67, indicating a +1.97% change from the previous session's end. The stock outpaced the S&P 500's daily gain of 1.77%. On the other ...

Boston Scientific BSX -1.50% Get Free Report has outperformed the market over the past 5 years by 8.22% on an annualized basis producing an average annual return of 25.31%. Currently, Boston ...

Boston Scientific has shown high revenue and EPS growth rates in recent years. See why I recommend a hold rating for BSX ...

Bullish option flow detected in Boston Scientific (BSX) with 2,458 calls trading, 1.0x expected, and implied vol increasing almost 2 points to ...

Boston Scientific (NYSE: BSX) is buying into the business of acquisitions. The Marlborough medical device firm has announced its second acquisition thus far in 2025. Boston Scientific Corp. has ...

Boston Scientific (BSX) closed the latest trading day at $102.67, indicating a +1.97% change from the previous session's end. The stock outpaced the S&P 500's daily gain of 1.77%. On the other hand, ...